Welcome to The Intel, the Visiopharm Newsletter that brings you our latest news and digital pathology content each month. Here are the highlights of this month:

• Check out our selection of the latest Phenoplex™ publications!
• 6 spatial biology studies presented at SITC in Houston.
• Molecular Instruments and Visiopharm announce strategic partnership
• Visiopharm’s Precision Pathology APPs now Integrated with PathAI’s AISight^® Image Management System

 As always, feel free to get in touch if you have any questions or would like to book a demo. You can also check out our Resources page for the latest guides, posters and webinars.

Check out our selection of the latest Phenoplex™ publications!

Crossing multiple indications and disease areas, Phenoplex, our complete workflow for all your multiplexed image analysis needs, is being used for generating results by researchers across all fields. Check out our selection of this year's papers.

Congratulations to the authors and their teams.

Explore 6 spatial biology studies presented at SITC

Curious about the scientific power of Oncotopix Discovery and Phenoplex? At the Society for Immunotherapy of Cancer (SITC) annual event, we presented 6 posters showcasing how our AI-driven workflows are advancing research—from phenotyping to spatial metrics for immuno-oncology and beyond.

1. Check out the powerful combination of SignalStar™ mIHC panel and Visiopharm’s Phenoplex™ software. Download the poster.
2. Tired of manual ROI and AOI selection on your GeoMx DSP images? Download this poster and discover a new way.
3. A deep learning approach to guide acquisition region selection for imaging mass cytometry (A powerful combination of Phenoplex with Standard BioTools’ Hyperion™ XTi Imaging System). Download the poster.
4. Phenoplex's impact on glioblastoma research. Download the poster.
5. Intrigued by how #Phenoplex can help you analyze millions of cells from Orion™ images? Check out this poster.
6. Novel collaboration in RNA-ISH analysis with Molecular Instruments. Download the poster.

Novel collaboration in RNA-ISH analysis

Visiopharm is thrilled to announce our strategic partnership with Molecular Instruments to advance clinical-grade RNA-ISH!
 
This collaboration brings together MI’s clinical-grade HCR™ platform with Visiopharm’s Oncotopix® Discovery software, empowering users with a highly flexible, deep learning approach to precise and efficient image analysis for RNA-ISH assays.

We are introducing a new mini-survey section to our newsletter called, "Stain your opinion" as a way for us to get to know you better and be able to provide you with content you want. We'll ask a unique question each time and look forward to your answers. Here's our very first question:

How do you prefer to consume educational content?

Click to select your most preferred medium.

#VisiopharmCartoons

Unlock the power of digital pathology for faster, more accurate diagnoses and improved patient outcomes.